pUBLICATIONS & PRESENTATIONS
Publications
· Johnson, O. (2018). Change reaction: Securing a positive reaction to change. Christian Faith Publishing.
· Johnson, O. (2018). Book chapter: Black men changing the narrative through education. Walter McCollum, LLC.
· Johnson, O., Muszinski, D. 2017. Sponsors Ask: Is Our Trial Plan Realistic? Toward a Data-Driven Feasibility Assessment. http://www.appliedclinicaltrialsonline.com/sponsors-ask-our-trial-plan-realistic-toward-data-driven-feasibility-assessment
· Johnson, O. (2016). Evaluating key predictors of employee response to change in the pharmaceutical industry (Doctoral Dissertation, Walden University).
· Johnson, O. (2015). An evidenced-based approach to conducting clinical trial feasibility assessments. Clinical Investigation, London 5(5), 491-499.
· Palladino Kim, L., Johnson, O., O'Neill, B. (2012). Operational input from investigators for protocol feasibility assessment. Journal of Clinical Research Best Practices, 8(12).
· Johnson, O. (2012). Leveraging organizational data sources to forecast clinical trial timelines. Pharmaceutical Outsourcing: The Journal of Pharmaceutical & Biopharmaceutical Contract Manufacturing and Packaging. May-June Issue
· Johnson, O., van Adelsberg, J., Pearlman, D., et. al. (2005). Onset and duration of single-dose protection of montelukast against exercise-induced bronchospasm. Journal of Allergy and Clinical Immunology, 115(2) Supp 1:S11
· Knorr, B., Kuznetsova, O., Reiss, T., Beckford, E., Johnson, O., Dass, B., Becker, A. (2005). Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: A 56-week, randomized double-blind study. Journal of Allergy and Clinical Immunology, 115(2) Supp 1:S148
Presentations
· Johnson, O. 2018. How is real world data informing healthcare decision making. PCMG Outsourcing Conference, Malta, June 6-8
· Johnson, O. (2018). Partnering shared expertise and technology to optimize study planning. In L. Bannon (Chair). Cambridge Healthtech Institute: Summit For Clinical Operations Executives (scope), Orlando, FL
· Bannon, L., Johnson, O., & Fites, M. (2018). Partnering shared expertise and technology to optimize study planning. Citeline’s Webinar series.
· Johnson, O. (2016). Creating competent clinical research professionals through systematic evidence review. In L. Palladino (Chair), Systematic Evidence Review. Symposium conducted at the annual meeting of the Drug Information Agency (DIA), Philadelphia, PA.
· Johnson, O. (2016). Evaluating key predictors of employee response to change in the pharmaceutical industry. International Conference on Interdisciplinary Research Studies, Washington, DC.
· Johnson, O. (2014). Application of EHR data in clinical trial operations. Translational Medicine & Health Sciences Network Summit, Rochester, MN 10/6/14
· Johnson, O., Little, R (2014). Using a data driven approach with sites during the feasibility process to help ensure a more accurate and successful outcome. Association of Clinical research Professionals Conference, San Antonia, TX.
· Johnson, O. (2014). Next generation feasibility analysis. Cambridge Health Tech Institute's Webinar series, 4/8/14.
· Johnson, O., Harper, B. (2013). What is being done by industry to improve on site performance as it relates to patient retention? Centerwatch's Optimizing Trial Performance Conference, Las Vegas, NV.
· Johnson, O., Heilbronn, A. (2013). Working together on patient recruitment feasibility for the site - Sponsor & CRO perspective. Partnerships in Clinical Trials, Vienna, Austria
· Johnson, O. (2013). Enrollment goal failure: Do you have a recruitment or a feasibility issue? Site Solutions Summit, Amelia Island, FL
· Johnson, O. (2013). What sponsors want: The ideal institution. Western IRB Copernicus Group's Webinar series, 11/10/13.
· Johnson, O. (2012). Metrics and benchmarks: using data to improve clinical operations. In K. Wenzel (Chair), Clinical Trial Metrics Symposium. Symposium conducted at the annual meeting of the Drug Information Agency (DIA), Philadelphia, PA.
· Johnson, O. (2012, March). Leveraging electronic health records (EHR) for secondary use. In R. Tandon (Chair), The impetus for change in the post marketing arena. Symposium conducted at the annual meeting of the Partnerships for Contract Research Organizations (CROs), Orlando, FL.
· Johnson, O., White, E. (2012). Leveraging organizational data assets to forecast clinical trial timelines. Cambridge Healthtech Institute: Summit For Clinical Ops Executives (scope), Miami, FL, 2/7/12 - 2/9.
· Johnson, O., Drumright, L. (2010). Patient enrollment planning, tracking and modeling at Merck. Bio-it World
· Webinar Series, 10/26/10 - 10/26/10
· Johnson, O., Trewhella, N. (2010). How to obtain and utilize benchmarking data to predict and assess clinical trial performance. Clinical Performance Metrics and Benchmarking 6th Annual Summit, Philadelphia, PA, 9/20/10 - 9/21/10.
· Johnson, O. (2010). A sponsor's perspective on study feasibility. In B. Harper (Chair), No more questionnaires. Rethinking the study feasibility assessment process to ensure successful implementation. Symposium conducted at the annual meeting of the Drug Information Agency (DIA), Washington, DC.
